1. Home
  2. NIC vs TARS Comparison

NIC vs TARS Comparison

Compare NIC & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NIC
  • TARS
  • Stock Information
  • Founded
  • NIC 2000
  • TARS 2016
  • Country
  • NIC United States
  • TARS United States
  • Employees
  • NIC N/A
  • TARS N/A
  • Industry
  • NIC Major Banks
  • TARS Medicinal Chemicals and Botanical Products
  • Sector
  • NIC Finance
  • TARS Health Care
  • Exchange
  • NIC Nasdaq
  • TARS Nasdaq
  • Market Cap
  • NIC 1.9B
  • TARS 1.7B
  • IPO Year
  • NIC N/A
  • TARS 2020
  • Fundamental
  • Price
  • NIC $133.35
  • TARS $69.09
  • Analyst Decision
  • NIC Buy
  • TARS Strong Buy
  • Analyst Count
  • NIC 3
  • TARS 7
  • Target Price
  • NIC $145.33
  • TARS $67.14
  • AVG Volume (30 Days)
  • NIC 71.4K
  • TARS 737.2K
  • Earning Date
  • NIC 10-14-2025
  • TARS 11-12-2025
  • Dividend Yield
  • NIC 0.96%
  • TARS N/A
  • EPS Growth
  • NIC 26.37
  • TARS N/A
  • EPS
  • NIC 8.72
  • TARS N/A
  • Revenue
  • NIC $364,023,000.00
  • TARS $295,521,000.00
  • Revenue This Year
  • NIC N/A
  • TARS $137.28
  • Revenue Next Year
  • NIC $4.83
  • TARS $42.84
  • P/E Ratio
  • NIC $15.30
  • TARS N/A
  • Revenue Growth
  • NIC 10.19
  • TARS 254.45
  • 52 Week Low
  • NIC $91.24
  • TARS $32.91
  • 52 Week High
  • NIC $141.92
  • TARS $69.49
  • Technical
  • Relative Strength Index (RSI)
  • NIC 51.20
  • TARS 77.06
  • Support Level
  • NIC $129.79
  • TARS $56.25
  • Resistance Level
  • NIC $136.83
  • TARS $59.78
  • Average True Range (ATR)
  • NIC 2.80
  • TARS 2.58
  • MACD
  • NIC 0.04
  • TARS 1.15
  • Stochastic Oscillator
  • NIC 58.60
  • TARS 97.60

About NIC Nicolet Bankshares Inc.

Nicolet Bankshares Inc is a United States-based bank holding company's principal business is banking, consisting of lending and deposit gathering, as well as ancillary banking-related products and services, to businesses and individuals of the communities it serves, and the operational support to deliver, fund and manage. It offers a variety of loans, deposits, and related services to business customers especially small and medium-sized businesses and professional concerns, business deposit products, cash management services, international banking services, business loans, lines of credit, commercial real estate financing, construction loans, agricultural real estate or production loans, and letters of credit, as well as retirement plan services.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: